Vireo Growth (VREOF) Equity Ratio (2020 - 2026)

Vireo Growth's (VREOF) quarterly Equity Ratio came in at 0.32 in Q1 2026, up 73.71% year-on-year from 0.18 in Q1 2025, and down 15.82% quarter-over-quarter from 0.38 in Q4 2025.

Vireo Growth (VREOF) Equity Ratio (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Equity Ratio across 7 years of filings, most recently posting 0.32 for Q1 2026.

  • Equity Ratio for Q1 2026 came in at 0.32, up 73.71% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.32 (up 73.71% YoY), and the FY2025 annual result was 0.38, up 88.67% from the prior year.
  • Equity Ratio came in at 0.32 for Q1 2026 at Vireo Growth, down from 0.38 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.41 in Q2 2025 to a low of 0.12 in Q1 2024.
  • The 5-year median for Equity Ratio is 0.1 (2022), against an average of 0.1.
  • Across the five-year window, Equity Ratio tumbled 807.36% in 2024 and jumped 739.21% in 2025, its largest moves.
  • Vireo Growth's Equity Ratio stood at 0.02 in 2022, then sank by 504.93% to 0.09 in 2023, then jumped by 327.75% to 0.2 in 2024, then soared by 88.67% to 0.38 in 2025, then retreated by 15.82% to 0.32 in 2026.
  • The last three Equity Ratio figures came in at 0.32 (Q1 2026), 0.38 (Q4 2025), and 0.36 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.21
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.21
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 0.88
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.73
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 0.69
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.49
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.41
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 0.20
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.52
10 Vireo Growth - - 59.30 Mn 0.32

Historic Data

Download Data
DateValue
Mar 31, 2026 0.32
Dec 31, 2025 0.38
Sep 30, 2025 0.36
Jun 30, 2025 0.41
Mar 31, 2025 0.18
Dec 31, 2024 0.20
Sep 30, 2024 -0.06
Jun 30, 2024 -0.12
Mar 31, 2024 -0.12
Dec 31, 2023 -0.09
Sep 30, 2023 -0.07
Jun 30, 2023 -0.05
Mar 31, 2023 -0.01
Dec 31, 2022 0.02
Sep 30, 2022 0.10
Jun 30, 2022 0.14
Mar 31, 2022 0.18
Dec 31, 2021 0.26
Sep 30, 2021 0.33
Jun 30, 2021 0.53